Top Markets
#1 Purr Purr +56.55%
#2 Pons Pons +53.28%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 StonkBroker StonkBroker +30.71%
#5 Non-Playable Coin Non-Playable Coin +28.02%
#6 TENDIES TENDIES +26.79%
#7 Kinetiq Kinetiq +26.27%
#8 ApeX ApeX +25.71%
#9 Morpho Morpho +22.27%
#10 OriginTrail OriginTrail +21.30%
Coin of the day
Purr Purr
Setări
Limbă
ROMâNă
Monedă
USD
Temă
F-star Therapeutics, Inc. F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTX
Rang în acțiuni #21012
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.
Preț acțiune
$7.12
Ultima sincronizare: 2023-03-08
Capitalizare de piață
$117.03M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
GB
Tranzacționează F-star Therapeutics, Inc. (FSTX)

Categorie

Healthcare
Venituri pentru F-star Therapeutics, Inc. (FSTX)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale F-star Therapeutics, Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru F-star Therapeutics, Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH